14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ALXN
Delisted

Alexion Pharmaceuticals Stock Price (Quote)

$182.50
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $182.50 $182.50 Friday, 27th May 2022 ALXN stock ended at $182.50. During the day the stock fluctuated 0% from a day low at $182.50 to a day high of $182.50.
90 days $182.50 $182.50
52 weeks $174.72 $187.45

Historical Alexion Pharmaceuticals prices

Date Open High Low Close Volume
May 02, 2019 $133.71 $135.41 $132.21 $133.13 1 347 695
May 01, 2019 $135.86 $136.92 $134.05 $134.14 987 366
Apr 30, 2019 $135.19 $136.31 $132.59 $136.13 1 171 917
Apr 29, 2019 $134.52 $135.91 $133.96 $135.29 1 163 762
Apr 26, 2019 $136.00 $137.16 $132.61 $134.57 1 498 480
Apr 25, 2019 $131.00 $135.81 $128.93 $135.68 1 739 569
Apr 24, 2019 $132.00 $133.89 $127.70 $130.09 1 250 750
Apr 23, 2019 $128.68 $133.23 $128.15 $132.37 1 488 685
Apr 22, 2019 $126.48 $129.29 $126.10 $128.96 1 245 585
Apr 18, 2019 $126.66 $128.22 $122.68 $126.01 2 094 946
Apr 17, 2019 $137.32 $137.77 $124.40 $125.91 3 078 009
Apr 16, 2019 $138.15 $139.95 $136.58 $136.94 1 172 902
Apr 15, 2019 $136.87 $137.93 $135.39 $137.49 855 369
Apr 12, 2019 $138.40 $139.39 $135.83 $136.20 990 477
Apr 11, 2019 $141.38 $141.59 $137.24 $137.42 947 500
Apr 10, 2019 $138.02 $141.86 $137.35 $141.30 1 148 868
Apr 09, 2019 $139.17 $140.35 $137.21 $137.65 992 084
Apr 08, 2019 $141.21 $141.21 $138.58 $139.75 929 035
Apr 05, 2019 $139.97 $141.65 $139.66 $141.20 1 208 323
Apr 04, 2019 $140.07 $141.80 $139.01 $139.93 1 189 250
Apr 03, 2019 $139.66 $140.18 $138.37 $139.99 1 699 749
Apr 02, 2019 $135.58 $139.65 $135.09 $138.92 1 516 299
Apr 01, 2019 $136.58 $137.62 $135.20 $135.32 869 886
Mar 29, 2019 $134.50 $135.79 $133.37 $135.18 1 240 751
Mar 28, 2019 $134.65 $135.78 $131.73 $133.26 1 124 939
Click to get the best stock tips daily for free!

About Alexion Pharmaceuticals

Alexion Pharmaceuticals Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosp... ALXN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT